摘要
近年来新型神经调节肽BNP/NT-proBNP和Copeptin在心血管领域的应用,为临床医生提供了更为快速准确的手段,以及早了解心脏功能,对不同类型冠心病进行危险分层,从而做到早期干预、及时治疗,最大限度的降低心血管疾病的发病率和死亡率,并可对冠心病的疾病变化进行随访监测,评估其预后。本文就其生物学特性、与心力衰竭及冠心病的研究进展作一综述。
Recently years,the applications of new neuromodulator peptide BNP/NT-proBNP and Copeptinin clinical have provided clinicians more rapid and accurate means,let clinicians understand cardiac function earlier,and make risk stratification for different types of coronary heart disease. It can ;intervene earlier and give treatment timely,reduce morbidity and mortality of cardiovascular disease maximum,and it can follow-up monitor the changes of coronary heart disease and assess their prognosis. In this paper,the research progress of biological characteristics of new neuromodulator peptide,and the relationship with heart failure and coronary heart disease were summarized.
出处
《中国医药科学》
2013年第1期57-59,共3页
China Medicine And Pharmacy
关键词
脑钠肽
脑钠肽前体
和肽素
心力衰竭
冠心病
Brain natriuretic peptide
N-terminal pro-B-type natriuretic peptide
Copeptin
Heart failure
Coronaryheart disease
